IL-2-independent activation and proliferation in human T cells induced by CD28

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 1809-1816

  Boulougouris, George ^b   McLeod, Julie D ^b   Patel, Yusuf I ^b   Ellwood, Claire N ^b   Walker, Lucy S K ^b   Sansom, David M ^a  

^a University of Bath   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYCLOSPORIN A; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD28; ANTIGENS, CD80; CELL DIVISION; CHO CELLS; CRICETINAE; CYCLOSPORINE; CYTOKINES; DNA-BINDING PROTEINS; DRUG RESISTANCE; DRUG SYNERGISM; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-2; INTERPHASE; LYMPHOCYTE ACTIVATION; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; SOLUBILITY; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 0033566825     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28 deficient mice. Science 261:609.
2. Sadlack, B., H. Merz, H. Schorle, A. Schimple, A. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
3. June, C. H., J. A. Bluestone, L. M Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
4. Harding, F., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents the induction of anergy in T cell clones. Nature 356:607.
5. Jenkins, M. K., P. S. Taylor, S. D. Norton, and K. B. Urdahl. 1991. CD28 delivers a costimulatory signal involved in antigen specific IL-2 production by human T cells. J. Immunol. 147:2461.
6. Tan, P., C. Anasetti, J. Hansen, J. Melrose, M. Brunvand, J. Bradshaw, J. Ledbetter, and P. Linsley. 1993. Induction of alloantigen specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B-7/BB1. J. Exp. Med. 177:165.
7. Linsley, P., and J. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
8. Ledbetter, J. A., and P. S. Linsley. 1992. CD28 receptor cross-linking induces tyrosine phosphorylation of PLC γ1. Adv. Exp. Med. Biol. 323:23.
9. Timmerman, L. A., N. A. Clipstone, S. N. Ho, J. P. Northrop, and G. R. Crabtree. 1996. Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. Nature 383:837.
10. 3 in T cells. Eur. J. Immunol. 23:2572.
11. Ward, S. G., A. Wilson, L. Turner, J. Westwick, and D. M. Sansom. 1995. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin. Eur. J. Immunol. 25:526.
12. Edmead, C. E., Y. I. Patel, A. Wilson, G. Boulougouris, N. D. Hall, S. G. Ward, and D. M. Sansom. 1996. Induction of NF-κB and AP-1 by CD28 signalling involves both PI-3 kinase and acidic sphingomyelinase signals. J. Immunol. 57: 3290.
13. Pages, F., M. Ragueneau, R. Rottapel, A. Truneh, J. Nunes, J. Imbert, and D. Olive. 1994. Binding of phosphatidylinostol-3-OH kinase to CD28 is required for T cell signalling. Nature 369:327.
14. Crooks, M. E. C., D. R. Littman, R. H. Carter, D. T. Fearon, A. Weiss, and P. H. Stein. 1995. CD28-mediated costimulation in the absence of phosphatidylinositol-3-kinase association and activation. Mol. Cell. Biol. 15:6820.
15. Parry, R. V., K. Reif, G. Smith, D. M. Sansom, B. A. Hemmings, and S. G. Ward. 1997. Ligation of the T cell co-stimulatory receptor CD28 activates the serinethreonine protein kinase protein kinase B. Eur. J. Immunol. 27:2495.
16. Franke, T. F., S. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N., Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphoinositol 3-kinase. Cell 81:727.
17. Pai, S., V. Calvo, M. Wood, and B. E. Bierer. 1994. Cross-linking CD28 leads to activation of 70-kDa S6 kinase. Eur. J. Immunol. 24:2364.
18. Cefai, D., H. Schneider, O. Matangkasombut, H. Kang, J. Brody, and C. E. Rudd. 1998. CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. J. Immunol 160:2223.
19. McLeod, J. D., L. S. K. Walker, C. Ellwood, Y. I. Patel, G. Boulougouris, and D. M. Sansom. 1998. Activation of human T cells with superantigen and CD28 confers resistance to apoptosis by CD95. J. Immunol. 160:2072.
20. L. Immunity 3:87.
21. Noel, P. J., L. H. Boise, J. M. Green, and C. B. Thompson. 1996. CD28 co-stimulation prevents cell death during primary T cell activation. J. Immunol. 157:636.
22. Lucas, P. J., I. Negishi, K. Nakayama, L. E. Fields, and D. Y. Loh. 1995. Naive CD28 deficient T cells can initiate but not sustain an in vitro antigen specific immune response. J. Immunol. 154:5757.
23. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727.
24. Ullman, K. S., J. P. Northrop, C. L. Verweij, and G. R Crabtree. 1990. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function. Annu. Rev. Immunol. 8:421.
25. Sansom, D. M., A. Wilson, M. Boshell, J. Lewis, and N. D Hall. 1993. B7/CD28 but not LFA-3 CD2 interactions can provide third party costimulation for human T cell activation. Immunology 80:242.
26. Williams, D., M. Woodrow, D. Cantrell, and E. Murray. 1995. PKC is not a downstream effector of p21ras in activated T cells. Eur. J. Immunol. 25:42.
27. June, C., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472.
28. Linsley, P., J. Bradshaw, M. Umes, L. Grosmaire, and J. Ledbetter. 1993. CD28 engagement by B7/BB1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signalling. J. Immunol. 150:3161.
29. Ghosh, P., A. Sica, M. Cippitelli, J. Subleski, R. Lahesmaa, H. A. Young, and N. R. Rice. 1996. Activation of nuclear factor of activated T-cells in a cyclosporin A-resistant pathway. J. Biol. Chem 271:7700.
30. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131.
31. Jain, J., P. McCaffrey, Z. Miner, T. Kerppola, J. Lambert, G. Verdine, T. Curran, and A. Rao. 1993. The T cell transcription factor NF-ATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365:352.
32. McCaffrey, P. G., B. A. Perrino, T. R. Soderling, and A. Rao. 1993. NF-ATp a T lymphocyte DNA binding protein that is a target for calcineurin and immunosuppressive drugs. J. Biol. Chem. 268:3747.
33. ras. J. Exp. Med. 180:1067.
34. Hughes, C. C. W., and J. S. Pober. 1996. Transcriptional regulation of the interleukin-2 gene in human peripheral blood T cells. J. Biol. Chem. 271:5369.
35. Ghosh, P., T. Tan, N. R. Rice, A. Sica, and H. A. Young. 1993. The interleukin 2 CD28-responsive complex contains at least three members of the NF-κB family: c-Rel, p50, and p-65. Proc. Natl. Acad. Sci. USA 90:1696.
36. Lai, J. H., and T. H. Tan. 1994. CD28 signaling causes a sustained down-regulation of IκBα which can be prevented by the immunosuppressant rapamycin. J. Biol. Chem. 269:30077.
37. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thomson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
38. Raziwolf, Z., G. A. Hollander, and H. Reiser. 1996. Activation of CD4(+) T-lymphocytes from interleukin 2-deficient mice by costimulatory B7 molecules. Proc. Natl. Acad. Sci. USA 93:2903.
39. Khoruts, A., A. Mondino, K. A. Pape, S. L. Reiner, and M. K. Jenkins. 1998. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin-2-independent mechanism. J. Exp. Med 187:225.